Arcutis Biotherapeutics (ARQT) Earnings Date, Estimates & Call Transcripts

$25.61 -0.58 (-2.21%)

As of 08/17/2026 04:00 PM Eastern

Arcutis Biotherapeutics Earnings Summary

Arcutis Biotherapeutics posted Q2 2026 earnings on August 5, 2026, reporting an EPS of $0.11, which beat the consensus estimate of $0.06 by $0.05. Quarterly revenue was reported to be $129.86 million, above analysts' expectations of $118.85 million. With a trailing EPS of $0.21 and a P/E Ratio of 121.96, Arcutis Biotherapeutics' earnings are expected to grow 185.00% next year, from $0.40 to $1.14 per share.

Upcoming Q3 Earnings Date: Oct. 27After Market ClosesEstimated
Consensus EPS (Aug. 5): $0.06
Actual EPS (Aug. 5): $0.11 Beat By $0.05
Actual Revenue (Aug. 5): $129.86M

Q2 2026 Earnings Resources

ARQT Upcoming Earnings

Arcutis Biotherapeutics' next earnings date is estimated for Tuesday, October 27, 2026, based on past reporting schedules.

Slide Deck

Full Screen Slide Deck

Get Arcutis Biotherapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Arcutis Biotherapeutics and other key companies, straight to your inbox.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ARQT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ARQT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Arcutis Biotherapeutics Analyst EPS Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2026	1	-$0.08	-$0.08	-$0.08
Q2 2026	1	$0.04	$0.04	$0.04
Q3 2026	1	$0.17	$0.17	$0.17
Q4 2026	1	$0.25	$0.25	$0.25
FY 2026	4	$0.38	$0.38	$0.38
Q1 2027	1	$0.08	$0.08	$0.08
Q2 2027	1	$0.19	$0.19	$0.19
Q3 2027	1	$0.25	$0.25	$0.25
Q4 2027	1	$0.48	$0.48	$0.48

Arcutis Biotherapeutics Earnings History by Quarter

Time Frame

Start Date

End Date

Export

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue	Details
10/27/2026 (Estimated)	-	-	-	-	-	-	-	-
8/5/2026	Q2 2026	$0.0551	$0.11	+$0.0549	$0.11	$118.85M	$129.86M
5/6/2026	Q1 2026	-$0.02	-$0.09	-$0.07	-$0.09	$103.68M	$105.40M
2/25/2026	Q4 2025	$0.03	$0.13	+$0.10	-	$110.79M	$129.50M
10/28/2025	Q3 2025	-$0.10	$0.06	+$0.16	$0.06	$86.69M	$99.22M
8/6/2025	Q2 2025	-$0.18	-$0.13	+$0.05	-$0.13	$72.70M	$81.50M
5/6/2025	Q1 2025	-$0.21	-$0.20	+$0.01	-$0.20	$64.80M	$65.85M
2/25/2025	Q4 2024	-$0.28	-$0.09	+$0.19	-$0.09	$60.52M	$71.36M
11/6/2024	-	-$0.42	-$0.33	+$0.09	-$0.33	$38.05M	$44.76M

Arcutis Biotherapeutics Earnings - Frequently Asked Questions

Arcutis Biotherapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, October 27th, 2026 based off last year's report dates. Learn more on ARQT's earnings history.

In the previous quarter, Arcutis Biotherapeutics (NASDAQ:ARQT) reported $0.11 earnings per share (EPS) to beat the analysts' consensus estimate of $0.06 by $0.05. Learn more on analysts' earnings estimate vs. ARQT's actual earnings.

The conference call for Arcutis Biotherapeutics' latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Arcutis Biotherapeutics' latest earnings report can be read online.
Read Transcript

Arcutis Biotherapeutics' earnings report can be found in their filing with the SEC.
View SEC filing

Arcutis Biotherapeutics (NASDAQ:ARQT) has a recorded annual revenue of $376.07 million.

Arcutis Biotherapeutics (NASDAQ:ARQT) has a recorded net income of -$16.14 million. ARQT has generated $0.21 earnings per share over the last four quarters.

Arcutis Biotherapeutics (NASDAQ:ARQT) has a trailing price-to-earnings ratio of 121.96 and a forward price-to-earnings ratio of 64.03.

Arcutis Biotherapeutics' earnings are expected to grow from $0.40 per share to $1.14 per share in the next year, which is a 185.00% increase.

More Earnings Resources from MarketBeat

Related Companies

Earnings Tools

Latest Articles

Earnings data for NASDAQ:ARQT is sourced from Fiscal.ai, with the most recent quarter reported on 8/5/2026. New results are added as companies report their earnings.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Arcutis Biotherapeutics (ARQT) Earnings Date, Estimates & Call Transcripts